Aveanna Healthcare Holdings Insider Sold Shares Worth $8,365,352, According to a Recent SEC Filing-March 2024-www.financetom.com

Aveanna Healthcare Holdings Insider Sold Shares Worth $8,365,352, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Aveanna Healthcare Holdings Insider Sold Shares Worth $8,365,352, According to a Recent SEC Filing

May 26, 2025 11:44 AM

10:21 AM EDT, 05/21/2025 (MT Newswires) -- Paul R Vigano, 10% Owner, on May 19, 2025, sold 1,560,700 shares in Aveanna Healthcare Holdings ( AVAH ) for $8,365,352. Following the Form 4 filing with the SEC, Vigano has control over a total of 52,397,774 common shares of the company, with 52,397,774 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1832332/000095017025075601/xslF345X05/ownership.xml

Price: 5.62, Change: -0.13, Percent Change: -2.26

Previous page： Kenya looks to IPO state assets to draw private-sector investments, says President Ruto Next page： Ligand Unit Completes Merger With Channel Subsidiary to Form Pelthos Therapeutics

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Kenya looks to IPO state assets to draw private-sector investments, says President Ruto

Jul 2, 2025

LONDON, July 2 (Reuters) - Kenya is earmarking state assets for initial public offering in order to bring in more private sector investment, President William Ruto said in remarks at the London Stock Exchange on Wednesday. The government plans to start with listing the Kenya Pipeline Company via an initial public offering on the Nairobi Securities Exchange this year, Ruto...

Ligand Unit Completes Merger With Channel Subsidiary to Form Pelthos Therapeutics

Jul 2, 2025

07:31 AM EDT, 07/02/2025 (MT Newswires) -- Ligand Pharmaceuticals ( LGND ) said Wednesday its subsidiary LNHC completed a merger with a subsidiary of Channel Therapeutics ( CHRO ) . The combined company is called Pelthos Therapeutics and its stock will begin trading Wednesday on the NYSE American exchange under the ticker symbol PTHS, Ligand said. Pelthos raised $50.1 million...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

HLS Therapeutics' Vascepa Reimbursed Under Nova Scotia's Provincial Drug Plan

Jul 2, 2025

07:27 AM EDT, 07/02/2025 (MT Newswires) -- HLS Therapeutics ( HLTRF ) on Wednesday said Vascepa will now be reimbursed by the Nova Scotia Provincial Drug Plan. Vascepa will be reimbursed for the secondary prevention of cardiovascular events in statin-treated patients with established cardiovascular disease and elevated triglycerides, a statement said. The PLA [product listing agreement] with Nova Scotia Pharmacare...